Compare BNTX & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTX | ROL |
|---|---|---|
| Founded | 2008 | 1948 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 29.0B |
| IPO Year | 2019 | N/A |
| Metric | BNTX | ROL |
|---|---|---|
| Price | $95.02 | $59.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $137.40 | $66.20 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 11-03-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.21% |
| EPS Growth | N/A | ★ 9.81 |
| EPS | N/A | ★ 1.06 |
| Revenue | ★ $3,698,814,972.00 | $3,680,306,000.00 |
| Revenue This Year | $2.03 | $12.55 |
| Revenue Next Year | N/A | $9.44 |
| P/E Ratio | ★ N/A | $56.75 |
| Revenue Growth | 3.70 | ★ 11.17 |
| 52 Week Low | $81.20 | $45.34 |
| 52 Week High | $129.27 | $61.84 |
| Indicator | BNTX | ROL |
|---|---|---|
| Relative Strength Index (RSI) | 45.84 | 49.30 |
| Support Level | $94.00 | $60.27 |
| Resistance Level | $95.71 | $61.10 |
| Average True Range (ATR) | 1.74 | 0.87 |
| MACD | 0.52 | -0.07 |
| Stochastic Oscillator | 62.66 | 49.02 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. They also have a litany of other brands, which they use to pursue customers via alternative sales channels. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.